Assembly Biosciences, Inc. Increase (Decrease) in Security Deposits
Assembly Biosciences, Inc. (ASMB) reported Increase (Decrease) in Security Deposits of -$610.96 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2018-11-08
- Assembly Biosciences, Inc. increase (decrease) in security deposits for the quarter ending 2018-09-30 was -$543.78K.
- Assembly Biosciences, Inc. increase (decrease) in security deposits for the quarter ending 2018-06-30 was $18.86K.
- Assembly Biosciences, Inc. increase (decrease) in security deposits for the quarter ending 2018-03-31 was -$86.03K, a 724.97% decline year-over-year.
- Assembly Biosciences, Inc. increase (decrease) in security deposits for the quarter ending 2017-12-31 was $86.23K.
- Assembly Biosciences, Inc. increase (decrease) in security deposits for fiscal 2017 was -$84.19K.
- Assembly Biosciences, Inc. increase (decrease) in security deposits for fiscal 2016 was -$58.21K.
- Assembly Biosciences, Inc. increase (decrease) in security deposits for fiscal 2015 was -$82.15K.
- Assembly Biosciences, Inc. increase (decrease) in security deposits for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Security Deposits 3 month | Increase (Decrease) in Security Deposits 6 month | Increase (Decrease) in Security Deposits 9 month | Increase (Decrease) in Security Deposits 12 month | Increase (Decrease) in Security Deposits 12 month as first filed |
|---|---|---|---|---|---|
| 2018-09-30 | -$543.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$524.92K derived: sum of 2 quarters · filed 2018-11-08 | -$610.96K 10-Q · filed 2018-11-08 | -$524.73K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2018-06-30 | $18.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$67.18K 10-Q · filed 2018-08-08 | $19.05K derived: sum of 3 quarters · filed 2018-08-08 | -$79.48K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2018-03-31 | -$86.03K 10-Q · filed 2018-05-07 | $197.00 derived: sum of 2 quarters · filed 2018-05-07 | -$98.34K derived: sum of 3 quarters · filed 2018-11-08 | -$183.99K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-12-31 | $86.23K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$12.31K derived: sum of 2 quarters · filed 2018-11-08 | -$97.96K derived: sum of 3 quarters · filed 2018-11-08 | -$84.19K 10-K · filed 2018-03-08 | |
| 2017-09-30 | -$98.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$184.19K derived: sum of 2 quarters · filed 2018-11-08 | -$170.42K 10-Q · filed 2018-11-08 | -$220.44K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | -$85.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$71.88K 10-Q · filed 2018-08-08 | -$121.91K derived: sum of 3 quarters · filed 2018-08-08 | -$143.55K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | $13.77K 10-Q · filed 2018-05-07 | -$36.26K derived: sum of 2 quarters · filed 2018-05-07 | -$57.90K derived: sum of 3 quarters · filed 2018-05-07 | -$37.32K derived: sum of 4 quarters · filed 2018-05-07 | |
| 2016-12-31 | -$50.02K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$71.67K derived: sum of 2 quarters · filed 2018-03-08 | -$51.09K derived: sum of 3 quarters · filed 2018-03-08 | -$58.21K 10-K · filed 2018-03-08 | |
| 2016-09-30 | -$21.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$1.06K derived: sum of 2 quarters · filed 2017-11-01 | -$8.19K 10-Q · filed 2017-11-01 | -$35.22K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-06-30 | $20.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $13.46K 10-Q · filed 2017-08-09 | -$13.57K derived: sum of 3 quarters · filed 2018-03-08 | -$58.61K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-03-31 | -$7.12K 10-Q · filed 2017-05-08 | -$34.15K derived: sum of 2 quarters · filed 2018-03-08 | -$79.19K derived: sum of 3 quarters · filed 2018-03-08 | ||
| 2015-12-31 | -$27.03K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$72.07K derived: sum of 2 quarters · filed 2018-03-08 | -$82.15K 10-K · filed 2018-03-08 | ||
| 2015-09-30 | -$45.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$55.12K 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | -$10.08K 10-Q · filed 2016-08-09 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $0.00 10-K · filed 2017-03-02 | -$82.00K 10-K · filed 2015-03-12 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | |||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-13 | ||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |